Wilkinson, 2021 - Google Patents
Method Development for O-glycan Analysis and its Application to Parkinson's DiseaseWilkinson, 2021
View PDF- Document ID
- 408888057390973555
- Author
- Wilkinson H
- Publication year
External Links
Snippet
Glycosylation is the most common post-translational modification of proteins with glycoproteins performing roles in cell-cell interactions, protein folding and function. By observing glycosylation changes between control and diseased tissues, biomarkers may be …
- 206010061536 Parkinson's disease 0 title abstract description 17
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/5308—Immunoassay; Biospecific binding assay for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Reiding et al. | The benefits of hybrid fragmentation methods for glycoproteomics | |
Han et al. | Mass spectrometry of glycans | |
Geyer et al. | Strategies for analysis of glycoprotein glycosylation | |
JP4583168B2 (en) | Method for quantitative proteome analysis of glycoproteins | |
Thaysen-Andersen et al. | Advances in LC–MS/MS-based glycoproteomics: Getting closer to system-wide site-specific mapping of the N-and O-glycoproteome | |
Alley Jr et al. | High-sensitivity analytical approaches for the structural characterization of glycoproteins | |
Kailemia et al. | Oligosaccharide analysis by mass spectrometry: a review of recent developments | |
Lu et al. | Advancements in mass spectrometry-based glycoproteomics and glycomics | |
JP5116837B2 (en) | MS method for evaluating glycans | |
Mulagapati et al. | Decoding of O-linked glycosylation by mass spectrometry | |
Novotny et al. | Analytical glycobiology at high sensitivity: current approaches and directions | |
Sturiale et al. | The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation | |
WO2005111627A2 (en) | Methods and products related to the improved analysis of carbohydrates | |
WO2008128220A1 (en) | Proteolytic release of glycans | |
Harvey et al. | Fragmentation and ion mobility properties of negative ions from N‐linked carbohydrates: Part 7. Reduced glycans | |
Lazar et al. | Recent advances in the MS analysis of glycoproteins: Theoretical considerations | |
Fellenberg et al. | Glycan analysis: Scope and limitations of different techniques—A case for integrated use of LC-MS (/MS) and NMR techniques | |
Kuo et al. | Strategic applications of negative-mode LC-MS/MS analyses to expedite confident mass spectrometry-based identification of multiple glycosylated peptides | |
Ma et al. | Carboxyl-based CPMP tag for ultrasensitive analysis of disaccharides by negative tandem mass spectrometry | |
Brown et al. | Glycoproteome analysis of human serum and brain tissue | |
Wilkinson | Method Development for O-glycan Analysis and its Application to Parkinson's Disease | |
Wang et al. | Human prostate-specific antigen carries N-glycans with ketodeoxynononic acid | |
Amoresano et al. | Technical advances in proteomics mass spectrometry: identification of post-translational modifications | |
Xie | Mass Spectrometry-Based Characterization of Cell Surface Protein-Glycan Interactions | |
Kameyama | Glycomics using mass spectrometry |